Tag: ClotTriever
One-year CLOUT data demonstrate low rate of PTS following treatment with...
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
Expanding the treatment window for the effective management of DVT
“The median thrombus age of DVT patients treated in our centre is 14 days – says Dr Andrew Wigham from Oxford University Hospitals. –...
ClotTriever “makes fast, safe and efficient thrombectomy possible”
This advertorial is sponsored by Inari Medical
“We need to eliminate symptoms as fast as possible—it is not OK just to make things a little...
Why might CLOUT and DEFIANCE open the door to a new...
Steven Abramowitz (Washington DC, USA) explains the significance of the CLOUT registry—the only registry capturing data on mechanical thrombectomy in deep venous thrombosis (DVT)....
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14...
New mechanical thrombectomy systems unlock possibilities for the treatment of venous...
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
Mechanical thrombectomy with the ClotTriever and FlowTriever systems (Inari Medical) opens...
ClotTriever deemed a “game-changer” in deep vein thrombosis treatment
This advertorial, sponsored by Inari Medical, is only available in selected countries and geographies.
“I am finally very confident I have a device that...
Why ClotTriever is a “gamechanger” for the treatment of deep vein...
Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional...
